Entering text into the input field will update the search result below

Theratechnologies stock rises 9% on positive data from early-stage trial data of cancer therapy

Financial stock market graph. Selective focus.

Diego Thomazini

  • Theratechnologies (NASDAQ:THTX) stock rises ~9% after the company announced Q2 result and positive data from its dose escalation portion of Phase 1 study of TH1902 to treat in advanced resistant malignancies.
  • The company tightened it FY2022 revenue guidance to be

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
THTX
--
TH:CA
--